Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
disease | 1.000 | None | 0.959 | 6 | 67 | 1990 | 2020 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.400 | None | 0.967 | 5 | 0 | 1993 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
disease | 0.800 | strong | 0.982 | 5 | 16 | 1998 | 2020 | ||||||||
|
alpha fetoprotein | 0.429 | 0.885 | 1.1E-11 |
|
disease | 0.400 | None | 0.972 | 4 | 0 | 1977 | 2020 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
disease | 0.600 | None | 1.000 | 4 | 0 | 1985 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
disease | 0.400 | None | 0.989 | 4 | 0 | 1988 | 2020 | ||||||||
|
fatty acid synthase | 0.474 | 0.846 | 1.00 |
|
disease | 0.400 | None | 1.000 | 3 | 0 | 2004 | 2020 | ||||||||
|
actin beta | 0.325 | 0.923 | 0.99 |
|
disease | 0.400 | None | 0.972 | 2 | 0 | 1997 | 2020 | ||||||||
|
cyclin E1 | 0.538 | 0.731 | 0.97 |
|
disease | 0.600 | None | 0.941 | 2 | 0 | 2002 | 2020 | ||||||||
|
heat shock protein family A (Hsp70) member 5 | 0.434 | 0.885 | 0.77 |
|
disease | 0.400 | None | 0.974 | 2 | 0 | 2001 | 2020 | ||||||||
|
glypican 3 | 0.466 | 0.808 | 1.00 |
|
disease | 0.600 | None | 0.984 | 2 | 0 | 1997 | 2020 | ||||||||
|
CCAAT enhancer binding protein alpha | 0.496 | 0.692 | 0.55 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2003 | 2020 | ||||||||
|
hepatocyte growth factor | 0.374 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1992 | 2020 | ||||||||
|
solute carrier family 5 member 5 | 0.499 | 0.769 | 2.9E-03 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 2004 | 2020 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.700 | None | 0.987 | 2 | 0 | 1989 | 2020 | ||||||||
|
insulin like growth factor 1 receptor | 0.399 | 0.885 | 0.97 |
|
disease | 0.400 | None | 1.000 | 2 | 0 | 1996 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
disease | 0.700 | None | 0.920 | 2 | 2 | 1985 | 2020 | ||||||||
|
RB transcriptional corepressor 1 | 0.444 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.846 | 2 | 0 | 1994 | 2020 | ||||||||
|
3-hydroxy-3-methylglutaryl-CoA reductase | 0.529 | 0.692 | 1.00 |
|
disease | 0.340 | None | 1.000 | 2 | 0 | 1991 | 2020 | ||||||||
|
enhancer of zeste 2 polycomb repressive complex 2 subunit | 0.376 | 0.885 | 1.00 |
|
disease | 0.400 | None | 1.000 | 1 | 0 | 2007 | 2020 | ||||||||
|
epoxide hydrolase 1 | 0.500 | 0.846 | 3.2E-09 |
|
disease | 0.400 | None | 0.769 | 1 | 0 | 1995 | 2020 | ||||||||
|
solute carrier family 22 member 1 | 0.556 | 0.731 | 1.5E-22 |
|
disease | 0.380 | None | 1.000 | 1 | 0 | 2011 | 2020 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.983 | 1 | 0 | 2007 | 2020 | ||||||||
|
hyaluronan mediated motility receptor | 0.544 | 0.615 | 5.5E-21 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2017 | 2020 | ||||||||
|
signal transducer and activator of transcription 1 | 0.399 | 0.885 | 1.00 |
|
disease | 0.400 | None | 0.947 | 1 | 0 | 2004 | 2020 |